FDA Inspection
SGS North America Inc.SGS North America Inc. – FDA Inspection, Apr 24, 2019
Record Details
This FDA Inspection record concerns SGS North America Inc., with an inspection on April 24, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Vioela Respress (Issuing Officer)
View Company Profile
ID · c2f4967a-fdb0-46ab-b74d-e4b891e4c93f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1091237
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of SGS North America Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Chicago District Office | Drug Quality Assurance |
| September 18, 2025 | Not classified | Chicago District Office | |
| January 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2017 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| November 21, 2014 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for SGS North America Inc.
- FDA Inspection 1308948 - 2026-03-20
- FDA Inspection 1297328 - 2025-09-18
- FDA Inspection 1194448 - 2023-01-10
- FDA Inspection 1001725 - 2017-02-14
- FDA Inspection 904043 - 2014-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.